5 things to know before the market opens on Tuesday, January 25

Read Time:3 Minute, 18 Second

Here are the most important news, trends and analysis investors need to start their trading day:

1. Wall Street looks lower, Nasdaq down 2%

NYSE Trader, Jan. 24, 2022.

Source: NYSE

U.S. stock futures fell on Tuesday, with the Nasdaq down 2%, a day after the market saw a stunning turnaround. The Nasdaq fell as much as 4.9% on Monday before a surprising recovery to end the session up 0.6%. However, the tech-heavy index remained in correction, down 13.7% from November’s record close. The Dow Jones Industrial Average was down 1,115 points, or 3.25%, at Monday’s low, before closing up 0.3%. The average price of the 30 stocks was 6.6% below the record closing price earlier this month. The S&P 500 also closed up 0.3% after falling nearly 4% at one point on Monday, signaling correction territory and down more than 10% from its record close at the start of the new year.

2. The Fed may signal a March rate hike at the end of the meeting

U.S. Federal Reserve Chairman Jerome Powell speaks during a renomination hearing for the Senate Banking, Housing and Urban Affairs Committee on Capitol Hill in Washington, U.S., January 11, 2022.

Graeme Jennings | Reuters

Bond yields were higher on Tuesday as the Federal Reserve begins its two-day January meeting. The Fed’s policy statement and Chairman Jerome Powell’s news conference Wednesday afternoon are expected to reflect the central bank’s willingness to take the necessary steps to fight inflation. Against the backdrop of a sharp correction in stocks, Fed officials are expected to say they are prepared to raise interest rates from near zero as early as March after the tapering of bond purchases ends. There have been four rate hikes this year.

3. Pfizer and BioNTech launch Covid vaccine trial for omicron

A vaccinator draws a Pfizer-BioNTech coronavirus disease (COVID-19) pediatric vaccine in Lansdale, Pennsylvania, U.S., on December 5, 2021.

Hannah Bell Reuters

Pfizer and BioNTech on Tuesday launched a clinical study to evaluate the safety and efficacy of a vaccine against a variant of Covid omicron. “While current research and real-world data suggest that boosters continue to provide high levels of omicron protection against serious illness and hospitalization, we recognize the need to prepare in case this protection diminishes over time, with the potential for Help address omicron and there will be new variants in the future,” Kathryn Jensen, head of vaccine development at Pfizer, said in a statement.

4. Johnson & Johnson expects at least $3 billion in sales of new crown vaccines this year

Johnson & Johnson logo

SOPA Images | Light Rocket | Getty Images

Before the market opens on Tuesday, four Dow stocks will report quarterly results: 3M, American Express, Verizon and Johnson & Johnson. Johnson & Johnson, which makes one of three coronavirus vaccines approved for emergency use in the U.S., posted slightly higher-than-expected adjusted fourth-quarter earnings but missed revenue. However, the U.S. drugmaker has higher guidance for full-year 2022 sales and adjusted EPS. Johnson & Johnson expects its Covid vaccine to generate $3 billion to $3.5 billion in sales this year. Shares were down 1.8% in premarket trading.

5. IBM shares surge after quarterly earnings, revenue beat IBM

Smith Collection/Gado | Archive Photo | Getty Images

Dow stock Microsoft is set to report quarterly earnings after the close. IBM, also a component of the Dow, reported better-than-expected fourth-quarter adjusted earnings and revenue Monday night. The stock rose nearly 2% in premarket trading on Tuesday, giving up most of its 6% gain in after-hours trading as the tech giant declined to provide forward-looking earnings guidance. Intel and Apple report quarterly results on Wednesday and Thursday, respectively.

— Follow all market actions like a pro CNBC Pro. Get the latest information on the pandemic CNBC’s coronavirus coverage.

If you want to know more about business please go to https://updatednews24.com/category/business/

0 %
0 %
0 %
0 %
0 %
0 %
We use cookies to personalise content and ads, to provide social media features and to analyse our traffic. We also share information about your use of our site with our social media, advertising and analytics partners. View more
Cookies settings
Privacy & Cookie policy
Privacy & Cookies policy
Cookie name Active

Who we are

Suggested text: Our website address is: https://updatednews24.com.


Suggested text: When visitors leave comments on the site we collect the data shown in the comments form, and also the visitor’s IP address and browser user agent string to help spam detection. An anonymized string created from your email address (also called a hash) may be provided to the Gravatar service to see if you are using it. The Gravatar service privacy policy is available here: https://automattic.com/privacy/. After approval of your comment, your profile picture is visible to the public in the context of your comment.


Suggested text: If you upload images to the website, you should avoid uploading images with embedded location data (EXIF GPS) included. Visitors to the website can download and extract any location data from images on the website.


Suggested text: If you leave a comment on our site you may opt-in to saving your name, email address and website in cookies. These are for your convenience so that you do not have to fill in your details again when you leave another comment. These cookies will last for one year. If you visit our login page, we will set a temporary cookie to determine if your browser accepts cookies. This cookie contains no personal data and is discarded when you close your browser. When you log in, we will also set up several cookies to save your login information and your screen display choices. Login cookies last for two days, and screen options cookies last for a year. If you select "Remember Me", your login will persist for two weeks. If you log out of your account, the login cookies will be removed. If you edit or publish an article, an additional cookie will be saved in your browser. This cookie includes no personal data and simply indicates the post ID of the article you just edited. It expires after 1 day.

Embedded content from other websites

Suggested text: Articles on this site may include embedded content (e.g. videos, images, articles, etc.). Embedded content from other websites behaves in the exact same way as if the visitor has visited the other website. These websites may collect data about you, use cookies, embed additional third-party tracking, and monitor your interaction with that embedded content, including tracking your interaction with the embedded content if you have an account and are logged in to that website.

Who we share your data with

Suggested text: If you request a password reset, your IP address will be included in the reset email.

How long we retain your data

Suggested text: If you leave a comment, the comment and its metadata are retained indefinitely. This is so we can recognize and approve any follow-up comments automatically instead of holding them in a moderation queue. For users that register on our website (if any), we also store the personal information they provide in their user profile. All users can see, edit, or delete their personal information at any time (except they cannot change their username). Website administrators can also see and edit that information.

What rights you have over your data

Suggested text: If you have an account on this site, or have left comments, you can request to receive an exported file of the personal data we hold about you, including any data you have provided to us. You can also request that we erase any personal data we hold about you. This does not include any data we are obliged to keep for administrative, legal, or security purposes.

Where we send your data

Suggested text: Visitor comments may be checked through an automated spam detection service.
Save settings
Cookies settings